💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Cymabay Therapeutics Inc. (CBAY)
« Back to company indexCBAY Chatter Timeline
Stock Ticker for CBAY
Most Active Tweeters for CBAY
| User | Tweets |
|---|---|
| @quantisnow | 2 |
| @ShortAlgoTrades | 2 |
| @FlashAlert_me | 2 |
| @SismasStock | 2 |
| @insidersanalyt1 | 2 |
Recent Tweets for CBAY
 |
@Uncletrade1 $CBAY Awaiting Buy signal on CBAY https://t.co/R1gGRcHdaI December 2nd 2021, 4:12pm |
 |
@ShortAlgoTrades $CBAY Awaiting Buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/Ly0oex8aRp December 1st 2021, 3:12pm |
 |
@SismasStock $CBAY waiting for Buy signal on CBAY https://t.co/7QlGqs77TC November 30th 2021, 4:11pm |
 |
@shortablestocks $CBAY is short sale restricted for 2021-11-30. https://t.co/wa16uU6UF2 November 30th 2021, 2:11pm |
|
@ShortAlgoTrades $CBAY Awaiting buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp #Investing #trading https://t.co/jBxzwlzNxm November 30th 2021, 12:11pm |
 |
@newsfilterio Form SC 13G (statement of acquisition of beneficial ownership by individuals) filed with the SEC $CBAY https://t.co/Twcb0Z47qm November 30th 2021, 6:11am |
 |
@Tickeron $CBAY in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/FSEWLtQp0m November 29th 2021, 9:11pm |
|
@SismasStock $CBAY waiting for Buy signal on CBAY https://t.co/4n5jmTEUgT November 29th 2021, 8:11pm |
 |
@OryoJohn $CBAY: SC 13G Filed by TCG Crossover Management, LLC 7% November 29th 2021, 6:11pm |
 |
@FlashAlert_me $CBAY [15s. delayed] filed form SC 13G on November 29, 13:00:42 https://t.co/Hoz69gdPNo November 29th 2021, 6:11pm |
 |
@InsiderForms $CBAY TCG Crossover Management, LLC has filed Form SC 13G with SEC. Reporting 7.0% Ownership. Try Insider Forms mo… https://t.co/6Ipcl9SGqP November 29th 2021, 6:11pm |
 |
@quantisnow $CBAY ? SEC Form SC 13G filed by CymaBay Therapeutics Inc. https://t.co/sY8WlsZWQI 45 seconds delayed. November 29th 2021, 6:11pm |
 |
@LargeVoidBot 11:56 New 52wk Lows: $ARQT $CBAY November 29th 2021, 4:11pm |
 |
@ChartMill The Current Ratio of $CBAY is much better than the industry average of 4.22. https://t.co/ZnTUQ8rnJx https://t.co/9Rdn59SW6k November 26th 2021, 12:11am |
 |
@insidersanalyt1 *LARGE insiders PURCHASES* reported to SEC on 2021-11-23 for $CBAY $MCHX *Find all technical charts in the feed*.… https://t.co/Yvo5BEvGWs November 25th 2021, 5:11pm |
|
@insidersanalyt1 on 2021-11-22 $CBAY insiders' PURCHASED 2500000 securities equal to 2.95% of outstanding shares. Please follow and… https://t.co/W1HS37q91i November 25th 2021, 5:11pm |
 |
@PlugPortal InstitutionalBuys $CBAY #Insider https://t.co/2Gf2BPe4x2 November 23rd 2021, 9:11pm |
 |
@BioWino RT @fintel_io: Insider venBio Select Advisor LLC reports buying 2,500,000 shares of $CBAY for a total cost of $9,999,750.00 https://t.co/Ez… November 23rd 2021, 9:11pm |
 |
@fintel_io Insider venBio Select Advisor LLC reports buying 2,500,000 shares of $CBAY for a total cost of $9,999,750.00 https://t.co/EzeW7NDesD #FNTL November 23rd 2021, 9:11pm |
|
@FlashAlert_me $CBAY [15s. delayed] filed SEC form 4: 10% Owner Avoro Capital Advisors LLC: Transacted Derivative Securities on 2… https://t.co/Z9wGyCn5AO November 23rd 2021, 9:11pm |
|
@quantisnow $CBAY ? SEC Form 4 filed by Avoro Capital Advisors Llc https://t.co/kKVfItRmAb 45 seconds delayed. November 23rd 2021, 9:11pm |
 |
@DmitryKovalchuk @juliaskripkaser I would increase $CBAY (given they announce that the offering is successfully closed - it was expe… https://t.co/zrDt1pKoXZ November 23rd 2021, 3:11pm |
 |
@mrland_news $CBAY CymaBay Therapeutics Granted U.S. Patent #11,179,359 'Treatment of NAFLD and NASH' https://t.co/hmvn2pypoG @benzinga November 23rd 2021, 12:11pm |
 |
@bthefirsttoknow First out// $CBAY: CymaBay Therapeutics Granted U.S. Patent #11,179,359 'Treatment of NAFLD and NASH' https://t.co/lqIbBsy25p November 23rd 2021, 12:11pm |
 |
@ShogunTrade $CBAY Awaiting buy signal. Stock Trading Ideas by https://t.co/6vnULU2sSf https://t.co/gc1e6ldEzf November 22nd 2021, 2:11pm |
 |
@wallstreetmover Raymond James Analyst Reiterates Buy Steven Seedhouse, analyst at Raymond James, reiterates Buy Rating on $CBAY wi… https://t.co/2POrC5Mx2M November 21st 2021, 11:11am |
 |
@bot_hamster HamsterBot Says: $CBAY is placid, but some birds joshingly sing like a Stateless muskrat. The Prime Number is 599. November 20th 2021, 10:11am |
 |
@hesham_monica $CBAY Awaiting buy Signal. Free Trial https://t.co/wUyihfppva https://t.co/rCYESzLAnY November 19th 2021, 8:11pm |
|
@Tickeron $CBAY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/kCrplt1Mlu November 19th 2021, 5:11pm |
|
@Tickeron If you’re trading this week, Read This! $CBAY The volume increased for one day, resulting in a record-breaking dail… https://t.co/rCETXSygk9 November 19th 2021, 2:11pm |
 |
@1stOncology #CymaBay Announces Pricing of #PublicOffering of Common Stock and Pre-Funded Warrants $CBAY https://t.co/cOBnKQxQ93 November 19th 2021, 9:11am |
|
@1stOncology #CymaBay Announces Proposed #PublicOffering of Common Stock and Pre-Funded Warrants $CBAY https://t.co/vkP99hKml5 November 19th 2021, 9:11am |
|
@Tickeron Do you agree with the A.I. prediction? $CBAY Stochastic Oscillator left the oversold zone. #CymaBayTherapeutics… https://t.co/ba57xegpZb November 19th 2021, 6:11am |
|
@newsfilterio CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants $CBAY https://t.co/lubfcZVgAQ November 19th 2021, 5:11am |
|
@Tickeron Good move or bad move? $CBAY entered a Downtrend because Momentum Indicator dropped below the 0 level.… https://t.co/uGoz0MV9KN November 19th 2021, 4:11am |
|
@FlashAlert_me $CBAY [15s. delayed] filed form 8-K on November 18, 17:18:02 https://t.co/IwUSO2FW1x November 18th 2021, 10:11pm |
 |
@investor_feed $CBAY 8-K Cymabay Therapeutics (18 Nov, 5:18pm) ? Other Events; Financial Statements and Exhibits… https://t.co/ny4hgOuoeg November 18th 2021, 10:11pm |
|
@FlashAlert_me $CBAY [15s. delayed] filed form 424B5 on November 18, 17:11:46 https://t.co/0a01zF8E9j November 18th 2021, 10:11pm |
 |
@AlertTrade SOCIAL ACTIVITY: $CBAY - CymaBay Therapeutics Inc. https://t.co/5KFq0HurO2 ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 18th 2021, 9:11pm |
 |
@SwingTradeIdeas $CBAY is up 5.28% after hours on 52,502 volume. Now trading at $4.19. #CBAY #afterhoursscan November 18th 2021, 9:11pm |
 |
@lilnickysmith $CBAY popper November 18th 2021, 9:11pm |
|
@bot_hamster HamsterBot Says: $CBAY is explosive, but some birds seriously sing like a Mozambican ground hog. The Prime Number is 211. November 18th 2021, 8:11pm |
|
@AlertTrade RT @Briefingcom: $CBAY: CymaBay Therapeutics announces the pricing of its previously announced underwritten public offering of common... ht… November 18th 2021, 3:11pm |
 |
@SmallCapsDaily $CBAY CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire… https://t.co/9gnJtNXsts November 18th 2021, 3:11pm |
 |
@Briefingcom $CBAY: CymaBay Therapeutics announces the pricing of its previously announced underwritten public offering of commo… https://t.co/Hh8TXHVLIM November 18th 2021, 3:11pm |
 |
@MarketCurrents $CBAY - CymaBay Therapeutics prices ~$75M offering https://t.co/iL5As2sAO0 November 18th 2021, 1:11pm |
 |
@IngeniousStock ??? TIME. GROWTH. MONEY ? I.S.T. WATCHLIST FOR NOV. 18th 2021 (THURSDAY) PART 2 ? $CBAY - CymaBay Announces Prop… https://t.co/5L8k1sasoT November 18th 2021, 1:11pm |
 |
@MarcJacksonLA $CBAY CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants https://t.co/4eMxHO4Z7x November 18th 2021, 1:11pm |
|
@DmitryKovalchuk $CBAY Offering details: The shares of common stock are being sold at a public offering price of $4.00 per share, an… https://t.co/iDAnjMP2nc November 18th 2021, 1:11pm |
 |
@63_hyacinth CymaBay 15.625M share Spot Secondary priced at $4.00 $CBAY November 18th 2021, 1:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?